pubmed.ncbi.nlm.nih.gov

NBOMes-Highly Potent and Toxic Alternatives of LSD - PubMed

  • ️Wed Jan 01 2020

Review

NBOMes-Highly Potent and Toxic Alternatives of LSD

Jolanta B Zawilska et al. Front Neurosci. 2020.

Abstract

Recently, a new class of psychedelic compounds named NBOMe (or 25X-NBOMe) has appeared on the illegal drug market. NBOMes are analogs of the 2C family of phenethylamine drugs, originally synthesized by Alexander Shulgin, that contain a N-(2-methoxy)benzyl substituent. The most frequently reported drugs from this group are 25I-NBOMe, 25B-NBOMe, and 25C-NBOMe. NBOMe compounds are ultrapotent and highly efficacious agonists of serotonin 5-HT2A and 5-HT2C receptors (Ki values in low nanomolar range) with more than 1000-fold selectivity for 5-HT2A compared with 5-HT1A. They display higher affinity for 5-HT2A receptors than their 2C counterparts and have markedly lower affinity, potency, and efficacy at the 5-HT2B receptor compared to 5-HT2A or 5-HT2C. The drugs are sold as blotter papers, or in powder, liquid, or tablet form, and they are administered sublingually/buccally, intravenously, via nasal insufflations, or by smoking. Since their introduction in the early 2010s, numerous reports have been published on clinical intoxications and fatalities resulting from the consumption of NBOMe compounds. Commonly observed adverse effects include visual and auditory hallucinations, confusion, anxiety, panic and fear, agitation, uncontrollable violent behavior, seizures, excited delirium, and sympathomimetic signs such mydriasis, tachycardia, hypertension, hyperthermia, and diaphoresis. Rhabdomyolysis, disseminated intravascular coagulation, hypoglycemia, metabolic acidosis, and multiorgan failure were also reported. This survey provides an updated overview of the pharmacological properties, pattern of use, metabolism, and desired effects associated with NBOMe use. Special emphasis is given to cases of non-fatal and lethal intoxication involving these compounds. As the analysis of NBOMes in biological materials can be challenging even for laboratories applying modern sensitive techniques, this paper also presents the analytical methods most commonly used for detection and identification of NBOMes and their metabolites.

Keywords: NBOMe; analytical methods; metabolism; new psychoactive substances; phenethylamines; psychedelics; toxicity.

Copyright © 2020 Zawilska, Kacela and Adamowicz.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1

Chemical structures of main classes of psychedelics.

FIGURE 2
FIGURE 2

Main phase I metabolic pathways of 25I-NBOMe.

Similar articles

Cited by

References

    1. Abiero A., Botanas C. J., Sayson L. V., Custodio R. J., de la Peña J. B., Kim M., et al. (2019). 5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex. Behav. Brain Res. 359 828–835. 10.1016/j.bbr.2018.07.020 - DOI - PubMed
    1. Aghajanian G. K., Marek G. J. (1999). Serotonin and hallucinogens. Neuropsychopharmacology 21(Suppl. 2) 16–23. 10.1016/S0893-133X(98)00135-3 - DOI - PubMed
    1. Al-Iman A., AbdulMajeed B. A. (2017). NBOMe compounds: systematic review and data crunching of the surface web. Glob. J. Health Sci. 9 126–139.
    1. Ameline A., Farrugia A., Raul J. S., Kintz P. (2017). Retrospective demonstration of 25I-NBOMe acute poisoning using hair analysis. Curr. Pharm. Biotechnol. 18 786–790. 10.2174/1389201019666171129175148 - DOI - PubMed
    1. Andrabi S., Greene S., Moukaddam N., Li B. (2015). New drugs of abuse and withdrawal syndromes. Emerg. Med. Clin. North Am. 33 779–795. 10.1016/j.emc.2015.07.006 - DOI - PubMed

Publication types